ACLARIS THERAPEUTICS INC. - COMMON STOCK

Aclaris Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Corporate Update

27 Feb 2024 07:00:00 By Nasdaq GlobeNewswire

Aclaris Therapeutics Announces Leadership Changes and Strategic Business Review

16 Jan 2024 07:00:00 By Nasdaq GlobeNewswire

Aclaris Therapeutics Announces Top-line Results from 4-Week Phase 2b Trial of ATI-1777 for Mild to Severe Atopic Dermatitis

10 Jan 2024 07:00:00 By Nasdaq GlobeNewswire

Aclaris Therapeutics Provides Corporate Update

19 Dec 2023 16:01:00 By Nasdaq GlobeNewswire

Aclaris Therapeutics Announces Patent License Agreement with Sun Pharma for Alopecia

05 Dec 2023 16:01:00 By Nasdaq GlobeNewswire

NetDania - New 12 months Low: ACLARIS THERAPEUTICS INC. - COMMON STOCK

13 Nov 2023 09:45:10 By NetDania Notify

Aclaris Therapeutics Announces Top-line Results from 12-Week Phase 2b Trial of Oral Zunsemetinib (ATI-450) for Moderate to Severe Rheumatoid Arthritis and Provides Corporate Update

13 Nov 2023 07:00:00 By Nasdaq GlobeNewswire

Aclaris Therapeutics Reports Third Quarter 2023 Financial Results and Provides a Corporate Update

06 Nov 2023 07:00:00 By Nasdaq GlobeNewswire

NetDania - New 12 months Low: ACLARIS THERAPEUTICS INC. - COMMON STOCK

27 Oct 2023 16:01:18 By NetDania Notify

NetDania - New 12 months Low: ACLARIS THERAPEUTICS INC. - COMMON STOCK

26 Oct 2023 10:53:33 By NetDania Notify

NetDania - New 12 months Low: ACLARIS THERAPEUTICS INC. - COMMON STOCK

25 Oct 2023 09:46:06 By NetDania Notify

NetDania - New 12 months Low: ACLARIS THERAPEUTICS INC. - COMMON STOCK

24 Oct 2023 10:00:36 By NetDania Notify

NetDania - New 12 months Low: ACLARIS THERAPEUTICS INC. - COMMON STOCK

23 Oct 2023 11:04:04 By NetDania Notify

NetDania - New 12 months Low: ACLARIS THERAPEUTICS INC. - COMMON STOCK

19 Oct 2023 09:45:17 By NetDania Notify

NetDania - New 12 months Low: ACLARIS THERAPEUTICS INC. - COMMON STOCK

13 Oct 2023 09:45:04 By NetDania Notify

NetDania - New 12 months Low: ACLARIS THERAPEUTICS INC. - COMMON STOCK

12 Oct 2023 13:33:16 By NetDania Notify

NetDania - New 12 months Low: ACLARIS THERAPEUTICS INC. - COMMON STOCK

06 Oct 2023 09:53:45 By NetDania Notify

Aclaris Therapeutics Completes Enrollment in Phase 2b Study of ATI-1777 for Mild to Severe Atopic Dermatitis (ATI-1777-AD-202)

03 Oct 2023 07:00:00 By Nasdaq GlobeNewswire

Aclaris Therapeutics to Participate in the 2023 Cantor Global Healthcare Conference

20 Sep 2023 07:00:00 By Nasdaq GlobeNewswire

Aclaris Therapeutics Announces Positive Results from Phase 1 Multiple Ascending Dose Trial of ATI-2138, an Investigational Oral Covalent ITK/JAK3 Inhibitor

18 Sep 2023 07:00:00 By Nasdaq GlobeNewswire